Cargando…

Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma

BACKGROUND: The side population (SP) of cancer cells is reportedly enriched with cancer stem cells (CSCs), however, the functional role and clinical relevance of CSC marker molecules upregulated in the SP of head and neck squamous carcinoma (HNSCC) cells are yet to be elucidated. Patients with clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Habu, Noboru, Imanishi, Yorihisa, Kameyama, Kaori, Shimoda, Masayuki, Tokumaru, Yutaka, Sakamoto, Koji, Fujii, Ryoichi, Shigetomi, Seiji, Otsuka, Kuninori, Sato, Yoichiro, Watanabe, Yoshihiro, Ozawa, Hiroyuki, Tomita, Toshiki, Fujii, Masato, Ogawa, Kaoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610045/
https://www.ncbi.nlm.nih.gov/pubmed/26483189
http://dx.doi.org/10.1186/s12885-015-1732-9
_version_ 1782395890989793280
author Habu, Noboru
Imanishi, Yorihisa
Kameyama, Kaori
Shimoda, Masayuki
Tokumaru, Yutaka
Sakamoto, Koji
Fujii, Ryoichi
Shigetomi, Seiji
Otsuka, Kuninori
Sato, Yoichiro
Watanabe, Yoshihiro
Ozawa, Hiroyuki
Tomita, Toshiki
Fujii, Masato
Ogawa, Kaoru
author_facet Habu, Noboru
Imanishi, Yorihisa
Kameyama, Kaori
Shimoda, Masayuki
Tokumaru, Yutaka
Sakamoto, Koji
Fujii, Ryoichi
Shigetomi, Seiji
Otsuka, Kuninori
Sato, Yoichiro
Watanabe, Yoshihiro
Ozawa, Hiroyuki
Tomita, Toshiki
Fujii, Masato
Ogawa, Kaoru
author_sort Habu, Noboru
collection PubMed
description BACKGROUND: The side population (SP) of cancer cells is reportedly enriched with cancer stem cells (CSCs), however, the functional role and clinical relevance of CSC marker molecules upregulated in the SP of head and neck squamous carcinoma (HNSCC) cells are yet to be elucidated. Patients with clinical stage I/II (T1-2N0M0) tongue squamous cell carcinoma (TSCC) typically undergo partial glossectomy; however, development of delayed neck metastasis (DNM) tends to reduce their survival. In the present study, we aimed to determine the CSC markers in the SP of HNSCC cells along with their functions in cellular behaviors, and to clarify the association of these markers with DNM. METHODS: Flow cytometry was applied to isolate SP from main population (MP) in HNSCC cells. The expression of the CSC markers was examined by semi-quantitative RT-PCR and immunocytochemistry. In vitro proliferation, migration, and invasion assays were performed to assess cellular behaviors. Clinicopathological factors and immunohistochemical expressions of Oct3/4 and Nanog were evaluated using surgical specimens from 50 patients with stage I/II TSCC. RESULTS: SPs were isolated in all three cell lines examined. Expression levels of Oct3/4 and Nanog were higher in SP cells than MP cells. Additionally, cell migration and invasion abilities were higher in SP cells than MP cells, whereas there was no difference in proliferation. Univariate analysis showed that expression of Oct3/4 and Nanog, vascular and muscular invasion, and mode of invasion were significantly correlated with DNM. Multivariate logistic regression revealed that Oct3/4 expression (risk ratio = 14.78, p = 0.002) and vascular invasion (risk ratio = 12.93, p = 0.017) were independently predictive of DNM. Regarding the diagnostic performance, Oct3/4 showed the highest accuracy, sensitivity, and NPV of 82.0 %, 61.5 %, and 86.8 %, respectively, while vascular invasion showed the highest specificity and PPV of 94.6 % and 71.4 %, respectively. CONCLUSION: These results suggest that Oct3/4 and Nanog represent probable CSC markers in HNSCC, which contribute to the development of DNM in part by enhancing cell motility and invasiveness. Moreover, along with vascular invasion, expression of Oct3/4 can be considered a potential predictor for selecting patients at high risk of developing DNM.
format Online
Article
Text
id pubmed-4610045
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46100452015-10-20 Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma Habu, Noboru Imanishi, Yorihisa Kameyama, Kaori Shimoda, Masayuki Tokumaru, Yutaka Sakamoto, Koji Fujii, Ryoichi Shigetomi, Seiji Otsuka, Kuninori Sato, Yoichiro Watanabe, Yoshihiro Ozawa, Hiroyuki Tomita, Toshiki Fujii, Masato Ogawa, Kaoru BMC Cancer Research Article BACKGROUND: The side population (SP) of cancer cells is reportedly enriched with cancer stem cells (CSCs), however, the functional role and clinical relevance of CSC marker molecules upregulated in the SP of head and neck squamous carcinoma (HNSCC) cells are yet to be elucidated. Patients with clinical stage I/II (T1-2N0M0) tongue squamous cell carcinoma (TSCC) typically undergo partial glossectomy; however, development of delayed neck metastasis (DNM) tends to reduce their survival. In the present study, we aimed to determine the CSC markers in the SP of HNSCC cells along with their functions in cellular behaviors, and to clarify the association of these markers with DNM. METHODS: Flow cytometry was applied to isolate SP from main population (MP) in HNSCC cells. The expression of the CSC markers was examined by semi-quantitative RT-PCR and immunocytochemistry. In vitro proliferation, migration, and invasion assays were performed to assess cellular behaviors. Clinicopathological factors and immunohistochemical expressions of Oct3/4 and Nanog were evaluated using surgical specimens from 50 patients with stage I/II TSCC. RESULTS: SPs were isolated in all three cell lines examined. Expression levels of Oct3/4 and Nanog were higher in SP cells than MP cells. Additionally, cell migration and invasion abilities were higher in SP cells than MP cells, whereas there was no difference in proliferation. Univariate analysis showed that expression of Oct3/4 and Nanog, vascular and muscular invasion, and mode of invasion were significantly correlated with DNM. Multivariate logistic regression revealed that Oct3/4 expression (risk ratio = 14.78, p = 0.002) and vascular invasion (risk ratio = 12.93, p = 0.017) were independently predictive of DNM. Regarding the diagnostic performance, Oct3/4 showed the highest accuracy, sensitivity, and NPV of 82.0 %, 61.5 %, and 86.8 %, respectively, while vascular invasion showed the highest specificity and PPV of 94.6 % and 71.4 %, respectively. CONCLUSION: These results suggest that Oct3/4 and Nanog represent probable CSC markers in HNSCC, which contribute to the development of DNM in part by enhancing cell motility and invasiveness. Moreover, along with vascular invasion, expression of Oct3/4 can be considered a potential predictor for selecting patients at high risk of developing DNM. BioMed Central 2015-10-19 /pmc/articles/PMC4610045/ /pubmed/26483189 http://dx.doi.org/10.1186/s12885-015-1732-9 Text en © Habu et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Habu, Noboru
Imanishi, Yorihisa
Kameyama, Kaori
Shimoda, Masayuki
Tokumaru, Yutaka
Sakamoto, Koji
Fujii, Ryoichi
Shigetomi, Seiji
Otsuka, Kuninori
Sato, Yoichiro
Watanabe, Yoshihiro
Ozawa, Hiroyuki
Tomita, Toshiki
Fujii, Masato
Ogawa, Kaoru
Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
title Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
title_full Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
title_fullStr Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
title_full_unstemmed Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
title_short Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
title_sort expression of oct3/4 and nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage i/ii oral tongue squamous cell carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610045/
https://www.ncbi.nlm.nih.gov/pubmed/26483189
http://dx.doi.org/10.1186/s12885-015-1732-9
work_keys_str_mv AT habunoboru expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT imanishiyorihisa expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT kameyamakaori expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT shimodamasayuki expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT tokumaruyutaka expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT sakamotokoji expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT fujiiryoichi expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT shigetomiseiji expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT otsukakuninori expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT satoyoichiro expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT watanabeyoshihiro expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT ozawahiroyuki expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT tomitatoshiki expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT fujiimasato expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma
AT ogawakaoru expressionofoct34andnanogintheheadandnecksquamouscarcinomacellsanditsclinicalimplicationsfordelayedneckmetastasisinstageiiioraltonguesquamouscellcarcinoma